WallStreetZenWallStreetZen

NASDAQ: OCUP
Ocuphire Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for OCUP

Based on 2 analysts offering 12 month price targets for Ocuphire Pharma Inc.
Min Forecast
$20.00+890.1%
Avg Forecast
$20.00+890.1%
Max Forecast
$20.00+890.1%

Should I buy or sell OCUP stock?

Based on 2 analysts offering ratings for Ocuphire Pharma Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OCUP stock forecasts and price targets.

OCUP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-11

1 of 1

Forecast return on equity

Is OCUP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is OCUP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

OCUP revenue forecast

What is OCUP's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$15.1M-20.68%
Avg 2 year Forecast
$30.6M+60.74%
Avg 3 year Forecast
$63.3M+232.14%
OCUP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OCUP revenue growth forecast

How is OCUP forecast to perform vs Biotechnology companies and vs the US market?
Company
46.92%
Industry
38.94%
Market
10.52%
OCUP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OCUP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OCUP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCUP$2.02$20.00+890.10%Strong Buy
MAIA$2.48N/AN/A
EFTR$13.45$125.00+829.37%Buy
UNCY$1.46$4.50+208.22%Buy
ELDN$2.13$13.00+510.33%Buy

Ocuphire Pharma Stock Forecast FAQ

Is Ocuphire Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: OCUP) stock is to Strong Buy OCUP stock.

Out of 2 analysts, 1 (50%) are recommending OCUP as a Strong Buy, 1 (50%) are recommending OCUP as a Buy, 0 (0%) are recommending OCUP as a Hold, 0 (0%) are recommending OCUP as a Sell, and 0 (0%) are recommending OCUP as a Strong Sell.

If you're new to stock investing, here's how to buy Ocuphire Pharma stock.

What is OCUP's revenue growth forecast for 2024-2026?

(NASDAQ: OCUP) Ocuphire Pharma's forecast annual revenue growth rate of 46.92% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Ocuphire Pharma's revenue in 2024 is $19,049,000.On average, 1 Wall Street analysts forecast OCUP's revenue for 2024 to be $374,930,021, with the lowest OCUP revenue forecast at $374,930,021, and the highest OCUP revenue forecast at $374,930,021. On average, 1 Wall Street analysts forecast OCUP's revenue for 2025 to be $759,785,389, with the lowest OCUP revenue forecast at $759,785,389, and the highest OCUP revenue forecast at $759,785,389.

In 2026, OCUP is forecast to generate $1,569,941,920 in revenue, with the lowest revenue forecast at $1,569,941,920 and the highest revenue forecast at $1,569,941,920.

What is OCUP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OCUP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is OCUP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year OCUP price target, the average OCUP price target is $20.00, with the highest OCUP stock price forecast at $20.00 and the lowest OCUP stock price forecast at $20.00.

On average, Wall Street analysts predict that Ocuphire Pharma's share price could reach $20.00 by Mar 20, 2025. The average Ocuphire Pharma stock price prediction forecasts a potential upside of 890.1% from the current OCUP share price of $2.02.

What is OCUP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OCUP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.